适形调强放疗联合同步化疗在宫颈癌患者中的应用价值  

Application value of conformal intensity modulated radiotherapy combined with synchronous chemotherapy in patients with cervical cancer

作　　者：于晓彬 Yu Xiaobin(Department of Oncology and Radiotherapy,Nantong Ruici Hospital(The Fourth Clinical College of Yangzhou University),Nantong 226000,China)

机构地区：[1]南通瑞慈医院(扬州大学第四临床医学院)肿瘤放疗科,江苏南通226000

出　　处：《实用妇科内分泌电子杂志》2024年第4期76-78,共3页Electronic Journal of Practical Gynecological Endocrinology

摘　　要：目的探讨适形调强放疗联合同步化疗在宫颈癌患者中的应用价值。方法选择122例宫颈癌患者为研究对象,根据随机数字表法分为观察组和对照组,每组61例。对照组使用紫杉醇+顺铂进行化疗,观察组在对照组化疗基础上实施适形调强放疗技术,比较两组治疗效果及不良反应发生率。结果观察组客观缓解率、疾病控制率均高于对照组(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论宫颈癌患者采用适形调强放疗联合化疗的方案有助于提升整体治疗效果,未增加不良反应,值得临床推广与应用。Objective To investigate the application value of conformal intensity modulated radiotherapy combined with synchronous chemotherapy in patients with cervical cancer.Methods A total of 122 patients with cervical cancer were selected as research objects and divided into observation group and control group according to random number table method,61 cases in each group.The control group received chemotherapy with paclitaxel+cisplatin,and the observation group received conformal intensity modulated radiotherapy on the basis of chemotherapy in the control group.The therapeutic effect and incidence of adverse reactions were compared between the two groups.Results The objective remission rate and disease control rate of observation group were higher than those of control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion The combination of conformal intensity modulated radiotherapy and chemotherapy for cervical cancer patients can improve the overall therapeutic effect without increasing adverse reactions,which is worthy of clinical promotion and application.

关 键 词：宫颈癌 调强适形放疗 同步化疗 应用价值 

分 类 号：R737.33[医药卫生—肿瘤]